Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • h_manoj
    Junior Member
    • Oct 2012
    • 6

    #1

    htseq read counts different in separate runs

    Hello,

    I had used tophat2 to map a set of fastq files. I noticed that the reads mapped for some features were different in two separate runs (for eg., ENSMUSG00000047905 produced 4335 reads in one run while it shows only 2 reads in another run), even though I had kept all options constant in both runs. The only change was the annotation file. In the first try, I used the gencode M2 gtf file which contained only level 1 and level 2 features. In the second trial, I had used the complete gtf file. But, the feature (ENSMUSG00000047905) that I am checking has no difference in either annotation files.

    Details of ENSMUSG00000047905 in gencode level 1 and level 2 annotation file:
    login3$ grep ENSMUSG00000047905 gencode.vM2.annotation.gtf |grep -w gene
    chr6 HAVANA gene 67205619 67206083 . + . gene_id "ENSMUSG00000047905.10"; transcript_id "ENSMUSG00000047905.10"; gene_type "pseudogene"; gene_status "KNOWN"; gene_name "Gm8566"; transcript_type "pseudogene"; transcript_status "KNOWN"; transcript_name "Gm8566"; level 2; havana_gene "OTTMUSG00000024710.1";

    Details of ENSMUSG00000047905 in gencode complete annotation file:
    login3$ grep ENSMUSG00000047905 gencM2_levels1and2.gtf |grep -w gene
    chr6 HAVANA gene 67205619 67206083 . + . gene_id "ENSMUSG00000047905.10"; transcript_id "ENSMUSG00000047905.10"; gene_type "pseudogene"; gene_status "KNOWN"; gene_name "Gm8566"; transcript_type "pseudogene"; transcript_status "KNOWN"; transcript_name "Gm8566"; level 2; havana_gene "OTTMUSG00000024710.1";
    login3$

    What would be the reason for this? Is this expected? Appreciate any help!
    Thanks.
    Last edited by h_manoj; 02-06-2014, 12:42 PM.

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
27 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
43 views
0 reactions
Last Post SEQadmin2  
Working...